Investing Profile

Stacie Weninger

InvestorVC
President, FBRI at F-Prime Capital Partners
fprimecapital.com/people/stac...Massachusetts
Photo of Stacie Weninger, President at F-Prime Capital Partners
Your Intro Paths to Stacie Weninger

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Stacie Weninger on

cb
Current Investing Position
F-Prime Capital Partners President
Investment Range
$100K - $10.0M
Sweet Spot
$5.0M
Investments On Record
7

Stacie Weninger is on these Sector & Stage Rankings

Stacie Weninger's Investments On Record (5)

CompanyStageDateRound SizeTotal Raised
Atalanta Therapeutics
Series BJan 2025$97M
Series AJan 2021$110M
$210M
Co-investors: Jessica Alston (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Jason P. Hafler (Sanofi Ventures), Niall O’Donnell (RiverVest)
Tenvie Therapeutics
Series AJan 2025$200M
$200M
Co-investors: Alaa Halawa (Mubadala), Paul Berns (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners)
Engrail Therapeutics
Series BMar 2024$160M
$220M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Jasper Bos (Forbion), Niall O’Donnell (RiverVest), Heath Lukatch (Red Tree Venture Capital)
Neumora Therapeutics
Series AOct 2021$400M
$510M
Co-investors: Alaa Halawa (Mubadala), Robert Nelsen (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners)
Denali Therapeutics
Series BAug 2016$130M
Series AMay 2015$220M
$350M
Co-investors: Robert Nelsen (ARCH Venture Partners), Doug Cole (Flagship Ventures)